CIK 0001720580
- Non-accelerated filer
- Smaller reporting company
Adicet Bio, Inc.
Sign in to watch- Ticker
- ACET
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 26
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813305277
- Phone
- +1 617-482-2333
- Business address
- 131 DARTMOUTH STREET, 3RD FLOOR, BOSTON, MA, 02116
- Former names
- resTORbio, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 50 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-04 | Galimi Francesco SVP & Chief Medical Officer | Grant or award | +16,000 | 75,917 | ||
| 2022-08-04 | Galimi Francesco SVP & Chief Medical Officer | Shares withheld for taxes | −5,533 | $18.25 | $101K | 70,384 |
| 2022-08-04 | Aftab Blake Chief Scientific Officer | Grant or award | +16,000 | 54,967 | ||
| 2022-08-04 | Aftab Blake Chief Scientific Officer | Shares withheld for taxes | −5,533 | $18.25 | $101K | 49,434 |
| 2022-08-04 | Harvey Brian Nicholas Chief Financial Officer | Grant or award | +16,000 | 70,608 | ||
| 2022-08-04 | Harvey Brian Nicholas Chief Financial Officer | Shares withheld for taxes | −4,696 | $18.25 | $86K | 65,912 |
| 2022-08-04 | Healey Don Chief Technology Officer | Grant or award | +16,000 | 68,934 | ||
| 2022-08-04 | Healey Don Chief Technology Officer | Shares withheld for taxes | −5,533 | $18.25 | $101K | 63,401 |
| 2022-08-03 | Aftab Blake Chief Scientific Officer | Sale | −6,968 | $18.00 | $125K | 38,967 |
| 2022-08-01 | Aftab Blake Chief Scientific Officer | Sale | −6,968 | $16.64 | $116K | 45,935 |
| 2022-07-06 | Schor Chen President & CEO | Gift | −53,424 | 96,000 | ||
| 2022-07-06 | Schor Chen President & CEO | Gift | +53,424 | 143,260 | ||
| 2022-07-05 | Aftab Blake Chief Scientific Officer | Sale | −1,363 | $14.50 | $20K | 52,903 |
| 2022-06-02 | GORDON CARL L Director | Grant or award · Stock Option (Right to Buy) | +18,500 | 18,500 | ||
| 2022-06-02 | Sinclair Andrew Director | Grant or award · Stock Option (Right to Buy) | +18,500 | 18,500 | ||
| 2022-06-02 | Sanna Bastiano Director | Grant or award · Stock Option (Right to Buy) | +18,500 | 18,500 | ||
| 2022-06-02 | Kauffman Michael Director | Grant or award · Stock Option (Right to Buy) | +18,500 | 18,500 | ||
| 2022-06-02 | Chodakewitz Jeffrey Director | Grant or award · Stock Option (Right to Buy) | +18,500 | 18,500 | ||
| 2022-06-02 | DUBIN STEVE Director | Grant or award · Stock Option (Right to Buy) | +18,500 | 18,500 | ||
| 2022-06-02 | Jakobovits Aya Director | Grant or award · Stock Option (Right to Buy) | +18,500 | 18,500 |
Page 17 of 24 · 478 trades